INDIANAPOLIS and SOUTH SAN FRANCISCO, Calif., June 20, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and DICE Therapeutics, Inc....

Data Presented at Late-Breaking Session at Heart Rhythm Society 2023: Paves Way for Premarket Approval Application for Federal Drug...

Multi-year collaboration will facilitate the co-development of optimized therapeutics that bind to challenging targets in ways...

Hypoimmune-modified allogeneic CD19-directed CAR T cells can evade immune detection and kill tumor cells in a novel humanized allogeneic...

Ring raised a total of $86.5 million from new and returning investors, validating its unique approach to creating next-generation...

Proprietary delivery platform, based on endogenous human proteins, offers the potential to enable genetic medicines across a broad range...

RNA Gene Writing™ platform demonstrates clinically relevant levels of in vivo rewriting in the genome of liver cells of non-human...

Zotatifin continues to show favorable activity profile, including two confirmed partial responses (PR) among seven heavily pretreated...

The 1950s are widely recognized as one of the most important decades in biology. This is, in large part, due to the discovery of the...